HF Foods Adopts Poison Pill Days After CEO Lost Director Vote
Contested
Company Background
HF Foods Group (Nasdaq: HFFG) is a Delaware corporation with a market capitalization of approximately $101.6 million. Xi "Felix" Lin serves as President and Chief Executive Officer. The company held its 2026 annual meeting on June 5 with a notably high 82% of shares represented — 44,025,014 shares in person or by proxy.
The meeting produced an unusually broad rebuke of management across multiple proposals. Two of the four director nominees failed to win majority support. The advisory say-on-pay vote on 2025 executive compensation also failed. Shareholders separately expressed a preference for annual future say-on-pay votes, a signal of continued scrutiny.
Despite the vote outcomes, the Nominating and Governance Committee and the board determined that both failed nominees should remain. That decision, and the reasoning offered to support it, set the stage for what happened a week later.
What Was Disclosed
A Preferred Stock Rights Agreement — commonly known as a poison pill — was entered into on June 12, 2026, between HF Foods and Equiniti Trust Company, LLC, as rights agent. The board declared a dividend of one right per outstanding share of common stock, with a record date of June 22, 2026. Each right entitles the holder to purchase one one-thousandth of a share of newly designated Series AA Participating Preferred Stock at an exercise price of $9.55, subject to adjustment.
The pill is triggered if any person or group acquires beneficial ownership of 15% or more of the common stock without board approval. Upon a trigger, each right held by non-triggering shareholders entitles them to purchase common stock with a then-current market value of twice the $9.55 exercise price — effectively diluting the triggering party's stake by half. Rights held by the triggering party become void. If a triggered company is subsequently merged or transfers more than 50% of its assets, the flip-over provision extends the same doubling mechanism to shares of the acquirer. The rights expire at 5:00 p.m. New York time on June 10, 2027.
The board's stated rationale goes beyond standard anti-takeover language. The Rights Agreement was adopted to protect against "unreported stockholder group formation activity and attempted unsolicited, nonpublic takeover efforts by certain stockholders that the Company believes to be in violation of applicable law and not aligned with the best interests of the Company and its stockholders." A companion Certificate of Designation for the Series AA Preferred Stock was filed with the Delaware Secretary of State on June 12, 2026.
Why It Matters
At the June 5 annual meeting, CEO Lin received 20,020,113 votes against his election versus 19,629,099 in favor — a margin of roughly 391,000 votes. Taylor's deficit was larger: 20,466,587 against versus 19,194,335 for, a gap of about 1.27 million votes. The board chose to retain both, invoking a claim that a significant stockholder had committed an administrative error and failed to submit voting instructions for approximately 1.4 million shares it intended to cast in favor of the nominees. The board calculated that, absent this error, both Lin and Taylor would have cleared the majority threshold — and that arithmetic is correct on its face. The say-on-pay vote, however, also failed by a comparable margin, a result the administrative error claim does not address.
The pill's one-year term — expiring June 10, 2027 — is shorter than the multi-year duration common in standing shareholder rights plans. That duration, combined with the board's reference to "certain stockholders" it believes are breaking the law, suggests the measure is aimed at a specific, identified party rather than being a general defensive posture. The filing does not name that party or describe the alleged violations.
For shareholders who voted against Lin and Taylor in good faith, the sequence is direct: their votes were overridden by the board citing an error by a third party, and within a week a mechanism was put in place that could significantly penalize any shareholder who accumulates a 15% stake to press the matter further. The board retains the power to redeem the rights at $0.001 per right at any time before a triggering event becomes irreversible, which gives it flexibility to negotiate — or not — with any party that approaches the threshold.
